Form 4: Opko Health Sells Shares of GeneDx Holdings Corp.

Opko Health, a significant shareholder of GeneDx Holdings Corp., has sold a portion of its Class A Common Stock in two transactions.

Summary

• Opko Health, Inc., a major shareholder of GeneDx Holdings Corp., reported the sale of Class A Common Stock in two separate transactions.
• On August 6, 2024, Opko Health sold 12,994 shares at a weighted average price of $29.3541 per share, with prices ranging from $29.00 to $29.75.
• On August 8, 2024, the company sold 100,000 shares at a weighted average price of $31.8238 per share, with prices ranging from $31.20 to $32.50.
• Following these transactions, Opko Health's direct ownership of GeneDx Holdings Corp. Class A Common Stock decreased from 2,971,570 to 2,871,570 shares.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting a transaction. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about share sales.

Industry Context

This filing indicates a change in ownership stake by a major shareholder, which is a common occurrence in the market. The reasons for the sale are not disclosed, but such transactions can be driven by various factors, including portfolio rebalancing or strategic decisions by the selling entity.

Key Dates